The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling

Acta Obstetricia Et Gynecologica Scandinavica
Fie PilsgaardA Pinborg

Abstract

Ovarian reserve can be determined by serum anti-Müllerian hormone (AMH) level and/or antral follicle count before controlled ovarian stimulation. The aim of controlled ovarian stimulation is to achieve an appropriate number of mature follicles and avoid complications such as ovarian hyperstimulation syndrome. Measurement of the ovarian reserve is useful for clinicians as it predicts the ovarian response to controlled ovarian stimulation. Further, it assists in giving the patient realistic expectations regarding the treatment. By determining the ovarian reserve, the most appropriate stimulation protocol and gonadotropin dose can be chosen specifically for each woman enabling so-called "individualized treatment" in line with the personalized treatment concept. Many benefits come with using AMH as a biomarker for ovarian reserve; the hormone is considered fairly cycle independent apart from a small decrease in the late follicular phase and there is no inter-observer variance. However, the use of AMH also has limitations; since the implementation of AMH in fertility treatment several AMH assays have been developed. This has made direct comparisons of AMH serum levels complicated. Currently, no international standardized assays exis...Continue Reading

References

Apr 18, 2006·Fertility and Sterility·Antonio La MarcaAnnibale Volpe
Nov 26, 2008·Fertility and Sterility·UNKNOWN Practice Committee of American Society for Reproductive Medicine
Jun 5, 2010·Fertility and Sterility·Karl R HansenLaTasha B Craig
Mar 23, 2011·Obstetrics and Gynecology·Anne Z SteinerDonna D Baird
Apr 21, 2011·Human Reproduction·A P FerrarettiUNKNOWN ESHRE working group on Poor Ovarian Response Definition
May 3, 2011·Human Reproduction·Andrea WeghoferNorbert Gleicher
Jul 27, 2011·PloS One·Thomas W KelseyW Hamish B Wallace
Apr 17, 2012·Reproductive Biomedicine Online·Annelies OverbeekCornelis B Lambalk
Oct 1, 2013·Human Reproduction Update·Antonio La Marca, Sesh Kamal Sunkara
Nov 26, 2013·Reproductive Biomedicine Online·Krzysztof LukaszukGrzegorz Jakiel
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Oybek RustamovPhilip W Pemberton
Jan 17, 2014·Human Reproduction Update·Didier DewaillyRichard A Anderson
May 2, 2014·Menopause : the Journal of the North American Menopause Society·David M RobertsonAngela Baerwald
Jan 15, 2015·Fertility and Sterility·UNKNOWN Practice Committee of the American Society for Reproductive Medicine
Feb 11, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Sharon Lie FongJoop S E Laven
Jun 16, 2015·Obstetrics and Gynecology International·Vinayak SmithBeverley Vollenhoven
Aug 19, 2015·Reproductive Biomedicine Online·Richard FlemingJane Ruman
Sep 16, 2015·Menopause : the Journal of the North American Menopause Society·Martine DepmannFrank J Broekmans
Oct 20, 2015·Fertility and Sterility·Geralyn Lambert-MesserlianRichard G Moore
Aug 11, 2016·The New England Journal of Medicine·Zi-Jiang ChenRichard S Legro

❮ Previous
Next ❯

Citations

Jul 3, 2020·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Carla PelusoBianca Bianco
Mar 20, 2019·International Journal of Molecular Sciences·Marek GowkielewiczMarta Majewska
Nov 3, 2020·Lupus Science & Medicine·Meghan AngleyPenelope P Howards

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.